CVS HEALTH Corp (CVS) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
CVS HEALTH’s revenue went from $177.5B in fiscal 2016 to $402.1B in fiscal 2025, growth of about 9.5% a year.
Net income in fiscal 2025 was $1.8B, a net margin of 0.4%; the best year in this period was 2023 with $8.3B.
Over the twelve months to September 30, 2026, revenue was $420.6B and net income $11.0B.
Free cash flow was $7.8B in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count rose 18% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $420.6B | $402.1B | $372.8B | $357.8B | $322.5B | $292.1B | $268.7B | $256.8B | $194.6B | $184.8B | $177.5B |
| Gross profit | $186.1B | $180.9B | $166.5B | $140.7B | $125.6B | $116.3B | $104.7B | $98.1B | $38.1B | $28.5B | $28.9B |
| Operating income | $15.1B | $4.7B | $8.5B | $13.7B | $8.0B | $13.3B | $13.9B | $12.0B | $4.0B | $9.5B | $10.4B |
| Net income | $11.0B | $1.8B | $4.6B | $8.3B | $4.3B | $8.0B | $7.2B | $6.6B | -$594M | $6.6B | $5.3B |
| EPS (diluted) | $8.61 | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 | $5.46 | $5.08 | $-0.57 | $6.44 | $4.90 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +7.8% | +4.2% | +10.9% | +10.4% | +8.7% | +4.7% | +32.0% | +5.3% | +4.1% | +15.8% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $18.7B | $10.6B | $9.1B | $13.4B | $16.2B | $18.3B | $15.9B | $12.8B | $8.9B | $8.0B | $10.1B |
| Capital spending | -$3.1B | -$2.8B | -$2.8B | -$3.0B | -$2.7B | -$2.5B | -$2.4B | -$2.5B | -$2.0B | -$1.9B | -$2.2B |
| Free cash flow | $15.6B | $7.8B | $6.3B | $10.4B | $13.4B | $15.7B | $13.4B | $10.4B | $6.8B | $6.1B | $7.9B |
| Dividends paid | $3.4B | $3.4B | $3.4B | $3.1B | $2.9B | $2.6B | $2.6B | $2.6B | $2.0B | $2.0B | $1.8B |
| Buybacks | — | $0 | $3.0B | $2.0B | $3.5B | $0 | $0 | $0 | $0 | $4.4B | $4.5B |
| Stock-based pay | $745M | $535M | $540M | $588M | $447M | $484M | $400M | $453M | $280M | $234M | $222M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $10.6B | $11.0B | $11.5B | $15.7B | $12.5B | $10.9B | $8.1B | $6.6B | $1.8B | $3.5B |
| Debt | — | $79.1B | $79.9B | $78.3B | $70.8B | $76.0B | $85.0B | $89.0B | $75.5B | $27.3B | $25.7B |
| Equity | — | $75.2B | $75.6B | $76.5B | $71.5B | $75.1B | $69.4B | $63.9B | $58.2B | $37.7B | $36.8B |
| Total assets | — | $253.5B | $253.2B | $249.7B | $228.3B | $233.0B | $230.7B | $222.4B | $196.5B | $95.1B | $94.5B |
| Shares (diluted) | 1.29B | 1.27B | 1.26B | 1.29B | 1.32B | 1.33B | 1.31B | 1.30B | 1.04B | 1.02B | 1.08B |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 44.2% | 45.0% | 44.7% | 39.3% | 38.9% | 39.8% | 39.0% | 38.2% | 19.6% | 15.4% | 16.2% |
| Operating margin | 3.6% | 1.2% | 2.3% | 3.8% | 2.5% | 4.6% | 5.2% | 4.7% | 2.1% | 5.2% | 5.9% |
| Net margin | 2.6% | 0.4% | 1.2% | 2.3% | 1.3% | 2.7% | 2.7% | 2.6% | -0.3% | 3.6% | 3.0% |
| FCF margin | 3.7% | 1.9% | 1.7% | 2.9% | 4.2% | 5.4% | 5.0% | 4.0% | 3.5% | 3.3% | 4.5% |
| ROIC | — | 2.4% | 4.1% | 6.7% | 4.2% | 6.7% | 6.6% | 5.8% | 2.4% | 11.8% | 10.2% |
| ROE | — | 2.4% | 6.1% | 10.9% | 6.0% | 10.7% | 10.3% | 10.4% | -1.0% | 17.6% | 14.4% |
Frequently asked questions
What is CVS HEALTH’s annual revenue?
$402.1B in fiscal 2025 and $420.6B over the twelve months to September 30, 2026.
How much profit does CVS HEALTH make?
Net income was $1.8B in fiscal 2025 (net margin 0.4%).
Is CVS HEALTH’s revenue growing?
Yes: revenue rose 7.8% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.